The Role of 18F-FDG-PET in Staging for The Surgery of Non-small Cell Lung Cancer
PDF
Cite
Share
Request
Original Article
VOLUME: 7 ISSUE: 3
P: 145 - 150
December 2006

The Role of 18F-FDG-PET in Staging for The Surgery of Non-small Cell Lung Cancer

1. Yedikule Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi 3. Cerrahi Kliniği, İstanbul, Türkiye
2. Yedikule Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi,3.Cerrahi Kliniği, İstanbul, Türkiye
3. İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Nükleer Tıp Anabilim Dalı, İstanbul, Türkiye
No information available.
No information available
Accepted Date: 18.07.2019
Online Date: 18.07.2019
Publish Date: 18.07.2019
PDF
Cite
Share
Request

Abstract

Abstract

Among the patients who were operated with the diagnosis of NSCLC between January 2003-May 2004, 21 cases who had 18F-FDG-PET examination were included in this study. The results of the thorax CT and the 18F-FDG-PET were compared with the postoperative pathologies. In two cases, the sensitivity of CT was 60%, the specificity was 75%, the positive predictive value was 42.8%, the negative predictive value 85.7%, and the accuracy was 71.4%. At the 18F-FDG-PET studies, the sensitivity was 100%, the specificity was 75%, the positive predictive value was 55.5%, the negative predictive value 100%, and the accuracy was 80.9%. CT and 18F-FDG-PET staging was compared with pathological staging. The numbers of the cases remaining at the same stage, being downstaged or up-staged were determined. According to the results of thorax CT, 8 (38.1%) cases remained at the same stage, while 9 (42.8%) cases were down-staged and 4 (19.1%) cases were up-staged. The comparison of 18F-FDG-PET results with histopathological results revealed that 14 (66.6%) cases remained at the same stage, while 4 (19.1%) cases were up-staged and 3 (14.3%) were down-staged. In conclusion, 18FFDG- PET is a reliable method with its high negative predictive value for the systematic evaluation of lung cancer and the staging of the mediastinum.

Keywords:
lung cancer, non-small cell, 18F-FDG-PET, staging